December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Intravitreal Injection of Human Immune Globulin in Rabbit eyes: Histopathology and Immunohistochemical Localization
Author Affiliations & Notes
  • R Buddi
    Eye Institute Medical College of Wisconsin Milwaukee WI
  • SL Perkins
    Eye Institute Medical College of Wisconsin Milwaukee WI
  • JM Burke
    Eye Institute Medical College of Wisconsin Milwaukee WI
  • DP Han
    Eye Institute Medical College of Wisconsin Milwaukee WI
  • Footnotes
    Commercial Relationships   R. Buddi, None; S.L. Perkins, None; J.M. Burke, None; D.P. Han, None. Grant Identification: Thomas M Aaberg Retina Research Fund; Research to Prevent Blindness, NY; NEI Core Grant EY01931
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4443. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R Buddi, SL Perkins, JM Burke, DP Han; Intravitreal Injection of Human Immune Globulin in Rabbit eyes: Histopathology and Immunohistochemical Localization . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4443.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the histopathological changes and immunohistochemical localization following intravitreal injection of human immune globulin (HIG) in rabbit eyes. This study is preliminary to a larger study determining the efficacy of HIG in staphylococcal exotoxin induced intraocular inflammation. Methods: Twenty four rabbit eyes were injected in the vitreous with 0.5, 2.5, 10, 20 and 30 mg of commercially available HIG (Gamimune, N). The eyes were harvested on post-injection day 1, 2, 3, and 5. Formalin fixed, paraffin embedded sections were used for H & E and immunoperoxidase staining with a human IgG specific antibody. Controls included normal rabbit eyes, eyes injected with diluent, and human tonsil (positive control). Results: Ten of the twenty-four eyes showed minimal mononuclear cell infiltration. This was predominantly pre-papillary or pre-retinal, appeared on day 2, and was independent of HIG dose. Intense HIG labeling was localized to the vitreous, posterior epithelial layer of the iris, inner layer of the ciliary epithelium, retina (predominantly inner nuclear layer and outer segments layer), and retinal pigment epithelium. This staining was noted at all time points. Ten eyes also showed linear focal staining in the outer choroids anterior to the equator. Intense staining was also noted in collagenous septae of the optic nerve head. Conclusion: Intravitreal injection of HIG induces minimal or no inflammation in rabbit eyes for the duration studied. In a normal eye, HIG persists in the vitreous cavity as well as other ocular structures for at least 5 days post-injection. High doses of intravitreal HIG can cross the intact retina, and in some eyes cross into the choroid. Recent studies by others suggest that periocular IgG molecules can cross an intact sclera, choroid, and retina. Trans-retinal migration of HIG could be secondary to the large amounts injected, and may therapeutically benefit toxin mediated intraocular inflammation such as in endophthalmitis.

Keywords: 629 vitreous • 398 endophthalmitis • 436 injection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×